Immunocore Holdings' stock has dropped 60% as Kimmtrak faces market saturation, but its pipeline could offer potential. Find ...

Jenny Strasburg is a reporter in London, where she writes for The Wall Street Journal about oil and gas, climate, the ...

Houston bounces back behind Jalen Green in Game 2 while Golden State struggles after Jimmy Butler's departure.

Ascletis is taking a low and slow approach to oral GLP-1 dose titration in a phase 2a test after getting a look at clinical ...

In the Phase III DESTINY-Breast09 trial, Enhertu (trastuzumab deruxtecan) and Perjeta (pertuzumab) significantly improved ...

During a live event, Caron A. Jacobson, MD, MMSc, and participants discussed how they decide on therapy for patients with relapsed/refractory diffuse large B-cell lymphoma.

The company's breakthrough puts the market one step closer to having an injection-free alternative for the treatment of ...

A Verve Therapeutics treatment was found to cut cholesterol levels by more than half—with just one shot. The stock jumped ...

Wall Street analysts said the results for Verve’s therapy appeared competitive on efficacy, while avoiding any major safety ...

Viking (VKTX) stock, Structure (GPCR) stock and others surge after Pfizer’s obesity drug setback. Read more here.

(This story was updated to reflect Tuesday's loss was the second-worst of the season for the Suns). The Phoenix Suns endured their second-worst loss of the season Tuesday, April 8, falling to the ...

Newborns are able to receive their first vaccine between six to 12 months of age, depending on whether they're travelling to a high risk area, and their second dose for full protection at 18 months.